| No headlines available for VGHAX. |
| | | Morningstar Overall Rating: |  | | Total Assets: | 8.51B | | Category: | Health | | Total Expense Ratio: | % |
|
| PERFORMANCE & RISK | 30-Nov-09 |
| YTD Return: | 18.34% | | 5y Avg Return: | 6.37% | | Rank in Category (ytd): | 85 | | % Rank in Category (ytd): | 51.52% | | Beta (3y): | 0.72 | | Morningstar Risk Rating: | Below average |
|
| The investment seeks long-term growth of capital. The fund normally invests at least 80% of assets in equities of companies engaged in the development, production, or distribution of products and services related to the health care industry. These companies include, among others, pharmaceutical firms, medical supply companies, and businesses that operate hospitals and other health care facilities. The fund also considers companies engaged in medical, diagnostic, biochemical, and other research and development activities. It may invest up to 50% of its assets in foreign stocks. | | | Fund Profile |
|
Help
0.32 (0.64%) 
Summary
Add VGHAX to Portfolio 
Download Data
